Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
8/5/2025
Metis Raises CNY 400M in Series D to Fuel AI-Driven Drug Development
8/5/2025
China Approves AstraZeneca's Ultomiris for AQP4+ NMOSD
8/5/2025
Innovent Secures FDA Clearance to Begin U.S. Trials for Oral GLP-1 Dru...
8/5/2025
MediLink and Akeso Launch First Clinical Trial Combining Ivonescimab w...
8/5/2025
Sanofi Attributes Praluent's China Exit to Global Supply Strain and St...
8/5/2025
China Biopharma Licensing Deals Soar in July, Driven by $500M Hengrui-...
8/5/2025
TenNor Files for Hong Kong IPO to Fund Breakthrough Antibacterial Prog...
8/5/2025
Sciwind in Talks to License Weight-Loss Drug to U.S. Partner, Eyes Glo...
8/5/2025
China Seeks Public Feedback on New Internet Drug and Device Informatio...
8/5/2025
China Issues 2025 Code of Ethics for Medical Professionals
8/5/2025
Sanofi Withdraws Praluent from China Amid Strategic Shift
8/4/2025
China Officially Establishes New Launch Price Mechanism for Innovative...
8/4/2025
Novartis Submits Zolgensma for Approval in China with Priority Review ...
8/4/2025
Alphamab's JSKN022 ADC Clears Major Regulatory Hurdle, Highlights Prec...
8/4/2025
China Grants First-Time Approval to Eight New Drugs in July 2025
8/4/2025
I-Mab Announces Pricing of $65M Underwritten Offering of ADS
8/2/2025
Recent Official and Executive Moves
8/2/2025
PD‑L1×VEGF Bispecific from ImmuneOnco Shows Strong Efficacy in China...
8/2/2025
Sumitomo Pharma Completes Divestiture of China Business to Marubeni Gr...
8/2/2025
China's Innovative Drug Market Surpasses CNY 400 Billion, Commercial M...
8/2/2025
Attec Secures Strategic Series A Funding to Advance Protein Degrader P...
8/1/2025
Chipscreen's Brain-Penetrant Aurora B Selective Inhibitor Receives FDA...
8/1/2025
Shanghai UTC Therapeutics Secures FDA IND Clearance for Novel MSLN CAR...
8/1/2025
Mabgeek Clinches CNY 260M Pre‑IPO Boost and Advances MG‑K10 Commerc...
8/1/2025
TenNor Therapeutics IPO Application Accepted by HKEX
8/1/2025
Lepu Biopharma Licenses Two T‑Cell Engagers to Excalipoint
8/1/2025
Everest Makes Strategic Equity Investment in I-Mab to Advance Oncology...
8/1/2025
Arrowhead Subsidiary Visirna Sells Rights to Hypertriglyceridemia Cand...
8/1/2025
China's Biotech Sector Faces Geopolitical Headwinds as Asia-Pacific Em...
8/1/2025
Wuxi AppTec Raises Nearly US$1B in Hong Kong to Fuel Global Expansion
Page:
3
/
56
Total number of articles:
1678
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit